RejuvenAir System
COPD with Chronic Bronchitis
Phase 3Active - Recruiting
Key Facts
About CSA Medical
CSA Medical, founded in 2004 and based in Lexington, MA, is pioneering a first-in-class interventional approach for Chronic Bronchitis (CB) with its RejuvenAir System. The device employs precise, bronchoscopically delivered cryospray to destroy dysfunctional airway cells while preserving the underlying extracellular matrix, aiming to restore normal mucociliary clearance. The company is in a critical late-stage clinical phase, with its SPRAY-CB trial actively recruiting across leading U.S. academic centers to demonstrate safety and efficacy. Success could position RejuvenAir as the first device to modify the disease pathology of CB, addressing a significant unmet need beyond symptomatic drug therapies.
View full company profile